CXCL10 and wet macular degeneration: Percentage of both CD4+ Th and CD8+ Tc cells expressing CXCR3 has been observed to be lower in the peripheral blood of patients with wet AMD in comparison to control subjects (62, 107), which may diminish the benefit of increased CXCL10 production following the COX-2 inhibition.